Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 3
1996 1
1997 2
1998 6
1999 5
2000 6
2002 1
2003 1
2004 5
2005 6
2006 2
2007 5
2008 9
2009 10
2010 20
2011 23
2012 10
2013 10
2014 22
2015 20
2016 24
2017 14
2018 8
2019 10
2020 15
2021 26
2022 24
2023 9
2024 15
2025 11
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative therapies for urological cancers.
Inokuchi J, Yokomizo A, Nishiyama N, Kitamura H, Eto M, Nishiyama H, Tomita Y. Inokuchi J, et al. Among authors: yokomizo a. Jpn J Clin Oncol. 2020 Apr 7;50(4):357-367. doi: 10.1093/jjco/hyaa013. Jpn J Clin Oncol. 2020. PMID: 32115649 Review.
[Atypical MDR].
Yokomizo A, Taniguchi K, Hasegawa S, Abe T, Kubo T, Makino Y, Wada M, Kohno K, Kuwano M. Yokomizo A, et al. Gan To Kagaku Ryoho. 1994 Jul;21(8):1123-9. Gan To Kagaku Ryoho. 1994. PMID: 7913311 Review. Japanese.
How to peer review.
Christensen NB, Yokomizo A. Christensen NB, et al. Among authors: yokomizo a. Int J Urol. 2010 Sep;17(9):754. doi: 10.1111/j.1442-2042.2010.02622.x. Int J Urol. 2010. PMID: 20727046 No abstract available.
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN Study.
Blas L, Shiota M, Kato T, Matsumoto R, Tohi Y, Sakamoto S, Yokomizo A, Kimura T, Furukawa J, Shoji S, Kume H, Goto T, Sekine Y, Sakai Y, Matsuoka Y, Hinata N, Kamoto T, Terada N, Akamatsu S, Sugimoto M, Eto M. Blas L, et al. Among authors: yokomizo a. Int J Urol. 2025 Jul;32(7):823-827. doi: 10.1111/iju.70063. Epub 2025 Apr 7. Int J Urol. 2025. PMID: 40195575
Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study.
Shiota M, Tatarano S, Kamoto T, Matsuyama H, Sakai H, Igawa T, Kamba T, Fujimoto N, Sekine Y, Kimura H, Narita S, Terada N, Momozawa Y, Akamatsu S, Habuchi T, Yokomizo A, Naito S, Eto M. Shiota M, et al. Among authors: yokomizo a. Endocr Relat Cancer. 2023 Jun 1;30(7):e230044. doi: 10.1530/ERC-23-0044. Print 2023 Jul 1. Endocr Relat Cancer. 2023. PMID: 37079309
Physical exercise increases binding of POMC to blood extracellular vesicles.
Santos MF, Randa J, Tai D, Vistoli G, Schahaf NA, Vittorio S, Fuentes G, Lauro R, Mosallaei S, Karbanová J, Yokomizo AMK, Corbeil D, Hightower CE, Lorico A. Santos MF, et al. Among authors: yokomizo amk. Proc Natl Acad Sci U S A. 2025 Dec 23;122(51):e2525044122. doi: 10.1073/pnas.2525044122. Epub 2025 Dec 16. Proc Natl Acad Sci U S A. 2025. PMID: 41400998 Free PMC article.
Risk Model for Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.
Tashiro K, Mori K, Shiota M, Fukuokaya W, Takamatsu D, Matsui Y, Kato M, Saito R, Yokomizo A, Tsutsumi M, Yamamoto Y, Edamura K, Miyake M, Morizane S, Yoshino T, Matsumoto R, Narita S, Kitamura H, Eto M, Kimura T; Japanese Urological Oncology Group. Tashiro K, et al. Among authors: yokomizo a. Int J Urol. 2025 Oct;32(10):1386-1392. doi: 10.1111/iju.70149. Epub 2025 Jun 16. Int J Urol. 2025. PMID: 40524484
Temporal changes in the urologist's practice behaviour of active surveillance for prostate cancer: analysis of prospective observational study cohort.
Tohi Y, Yokomizo A, Matsumoto R, Mori K, Sakamoto S, Shiota M, Sekine Y, Kanno T, Kato T, Fukuhara H, Sakai Y, Kohjimoto Y, Matsuda I, Goto T, Kawamura N, Kusuhara Y, Hashine K, Tsumura H, Naito Y, Sugimoto M; PRIAS-JAPAN. Tohi Y, et al. Among authors: yokomizo a. Jpn J Clin Oncol. 2025 Oct 7;55(10):1170-1176. doi: 10.1093/jjco/hyaf102. Jpn J Clin Oncol. 2025. PMID: 40577249
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer.
Tanegashima T, Shiota M, Terada N, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S, Kamiyama M, Tanaka N, Mitsuzuka K, Kato T, Narita S, Yasumoto H, Teraoka S, Kato M, Osawa T, Nagumo Y, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Kitamura H, Kamoto T, Eto M; Japanese Urological Oncology Group. Tanegashima T, et al. Among authors: yokomizo a. Int J Clin Oncol. 2025 Mar;30(3):551-558. doi: 10.1007/s10147-024-02681-2. Epub 2024 Dec 17. Int J Clin Oncol. 2025. PMID: 39688742
277 results